Cogent Biosciences
COGT
COGT
190 hedge funds and large institutions have $2.29B invested in Cogent Biosciences in 2025 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 85 increasing their positions, 46 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
33% more funds holding in top 10
Funds holding in top 10: 9 → 12 (+3)
20.8% more ownership
Funds ownership: 119.04% → 139.84% (+21%)
6% more funds holding
Funds holding: 179 → 190 (+11)
Holders
190
Holding in Top 10
12
Calls
$20.7M
Puts
$7.76M
Top Buyers
| 1 | +$92.1M | |
| 2 | +$76.5M | |
| 3 | +$70.9M | |
| 4 |
RI
RTW Investments
New York
|
+$49.8M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$39.9M |
Top Sellers
| 1 | -$103M | |
| 2 | -$52.8M | |
| 3 | -$23.9M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$22.1M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$14.7M |
